We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Kealey has served as MonarchBio's Chief Medical Officer since 2016, and has been with the company since 2011 when it was founded-based on his research into bioactive thin films at UCLA. In his current role, Dr. Kealey spearheads development of bioactive thin film-based products, with a focus on minimally-invasive implants for cell therapy and regenerative medicine.
During his time at MonarchBio Dr. Kealey has served as Principal Investigator on National Institutes of Health (NIH) grants totaling over $7 million dollars in funding. He also oversees preparation of materials for FDA and foreign regulatory bodies, and coordinates medical affairs for the company.
Prior to joining MonarchBio, Dr. Kealey was a resident physician and post-doctoral fellow in the UCLA Department of Surgery. Dr. Kealey earned his B.S. in Biochemistry and Molecular Biology from the University of Wisconsin – Madison and his M.D. from the University of Iowa Carver College of Medicine.
This speaker's sessions: